$43.96
Xenon Pharmaceuticals is a biotechnology business based in the US. Xenon Pharmaceuticals shares (XENE) are listed on the NASDAQ and all prices are listed in US Dollars. Xenon Pharmaceuticals employs 251 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Xenon Pharmaceuticals stock
How to buy Xenon Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – XENE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Xenon Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Xenon Pharmaceuticals stock price (NASDAQ: XENE)
Use our graph to track the performance of XENE stocks over time.Xenon Pharmaceuticals shares at a glance
Latest market close | $43.85 |
---|---|
52-week range | $27.99 - $50.99 |
50-day moving average | $38.70 |
200-day moving average | $40.64 |
Wall St. target price | $58.32 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.72 |
Is it a good time to buy Xenon Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Xenon Pharmaceuticals price performance over time
Historical closes compared with the close of $43.85 from 2024-07-25
1 week (2024-07-19) | 2.62% |
---|---|
1 month (2024-06-27) | 17.21% |
3 months (2024-04-26) | 8.27% |
6 months (2024-01-26) | -3.92% |
1 year (2023-07-27) | 22.38% |
---|---|
2 years (2022-07-27) | 30.58% |
3 years (2021-07-27) | 145.25% |
5 years (2019-07-26) | 356.77% |
Xenon Pharmaceuticals financials
Gross profit TTM | $-96,333,000 |
---|---|
Return on assets TTM | -17.09% |
Return on equity TTM | -23.95% |
Profit margin | 0% |
Book value | $11.76 |
Market Capitalization | $3.2 billion |
TTM: trailing 12 months
Xenon Pharmaceuticals share dividends
We're not expecting Xenon Pharmaceuticals to pay a dividend over the next 12 months.
Xenon Pharmaceuticals share price volatility
Over the last 12 months, Xenon Pharmaceuticals's shares have ranged in value from as little as $27.985 up to $50.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Xenon Pharmaceuticals's is 1.265. This would suggest that Xenon Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Xenon Pharmaceuticals overview
Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1. 6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc.
Frequently asked questions
What percentage of Xenon Pharmaceuticals is owned by insiders or institutions?Currently 0.378% of Xenon Pharmaceuticals shares are held by insiders and 100.333% by institutions. How many people work for Xenon Pharmaceuticals?
Latest data suggests 251 work at Xenon Pharmaceuticals. When does the fiscal year end for Xenon Pharmaceuticals?
Xenon Pharmaceuticals's fiscal year ends in December. Where is Xenon Pharmaceuticals based?
Xenon Pharmaceuticals's address is: 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8 What is Xenon Pharmaceuticals's ISIN number?
Xenon Pharmaceuticals's international securities identification number is: CA98420N1050 What is Xenon Pharmaceuticals's CUSIP number?
Xenon Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98420N105
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question